Szemes Z, Kovács R
Urological Ward, Central Hospital, Budapest, Hungary.
Acta Chir Hung. 1994;34(1-2):5-10.
Authors report on local mitomycin-C (MTM-C) therapy applied subsequent to the treatment by means of Nd-YAG laser in 59 superficial (Ta-T1) bladder neoplasms. Relapse-rate in the neoplasms could be reduced by using MTM-C accompanied by minor side-effects. Seventy-two % of patients have been free from relapse for the mean 44-month follow-up period. Authors also suggest that laser therapy may favourably be completed by local chemoprophylaxis in "high-risk" type superficial bladder neoplasms.
作者报告了在59例浅表性（Ta-T1期）膀胱肿瘤患者中，在钕钇铝石榴石激光治疗后应用局部丝裂霉素C（MTM-C）治疗的情况。使用MTM-C可降低肿瘤的复发率，且副作用较小。在平均44个月的随访期内，72%的患者无复发。作者还建议，在“高危”型浅表性膀胱肿瘤中，激光治疗可通过局部化学预防得到更好的效果。
